Sumitomo Pharma Co., Ltd.
SMDPY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23,116,000 | $29,047,000 | $143,478,000 | $202,984,000 |
| Short-Term Investments | $16,840,000 | $7,085,000 | $20,174,000 | $35,596,000 |
| Receivables | $74,840,000 | $81,023,000 | $95,908,000 | $151,407,000 |
| Inventory | $94,222,000 | $115,350,000 | $94,405,000 | $99,021,000 |
| Other Curr. Assets | $44,150,000 | $37,064,000 | $27,895,000 | $10,513,000 |
| Total Curr. Assets | $253,168,000 | $269,569,000 | $381,860,000 | $499,521,000 |
| Property Plant & Equip (Net) | $46,648,000 | $57,895,000 | $58,909,000 | $64,091,000 |
| Goodwill | $197,406,000 | $199,783,000 | $209,415,000 | $195,144,000 |
| Intangibles | $172,509,000 | $195,652,000 | $329,314,000 | $398,692,000 |
| Long-Term Investments | $72,339,000 | $161,711,000 | $144,399,000 | $127,909,000 |
| Tax Assets | $534,000 | $0 | $10,845,000 | $22,650,000 |
| Other NC Assets | $0 | $22,896,000 | $0 | $0 |
| Total NC Assets | $489,436,000 | $637,937,000 | $752,882,000 | $808,486,000 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $742,604,000 | $907,506,000 | $1,134,742,000 | $1,308,007,000 |
| Liabilities | – | – | – | – |
| Payables | $38,544,000 | $38,544,000 | $13,403,000 | $22,455,000 |
| Short-Term Debt | $46,440,000 | $289,298,000 | $95,248,000 | $30,548,000 |
| Tax Payable | $1,577,000 | $1,348,000 | $24,053,000 | $7,583,000 |
| Deferred Revenue | $0 | $0 | $151,952,000 | $140,034,000 |
| Other Curr. Liab. | $154,042,000 | $158,685,000 | $88,038,000 | $77,753,000 |
| Total Curr. Liab. | $240,603,000 | $515,474,000 | $372,694,000 | $278,373,000 |
| LT Debt | $258,982,000 | $138,566,000 | $251,124,000 | $253,996,000 |
| Deferred Rev, NC | $0 | $0 | $16,877,000 | $27,932,000 |
| Deferred Tax Liab, NC | $26,550,000 | $38,211,000 | $36,505,000 | $26,550,000 |
| Other NC Liab. | $46,990,000 | $59,119,000 | $50,760,000 | $47,587,000 |
| Total NC Liab. | $332,522,000 | $235,896,000 | $355,266,000 | $356,065,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $8,980,000 | $11,656,000 | $15,496,000 |
| Total Liabilities | $573,125,000 | $751,370,000 | $727,960,000 | $634,438,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $22,400,000 | $22,400,000 | $22,400,000 | $22,400,000 |
| Retained Earnings | $46,784,000 | -$22,665,000 | $280,999,000 | $514,210,000 |
| AOCI | $100,977,000 | $157,010,000 | $104,032,000 | $55,234,000 |
| Other Equity | -$682,000 | -$682,000 | -$682,000 | $16,044,000 |
| Total Equity | $169,479,000 | $156,063,000 | $406,749,000 | $607,888,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $73,000 | $33,000 | $65,681,000 |
| Total Liab. & Tot. Equity | $742,604,000 | $907,506,000 | $1,134,742,000 | $1,308,007,000 |
| Net Debt | $282,306,000 | $398,817,000 | $202,894,000 | $81,560,000 |